$139.21
1.64% today
Nasdaq, May 02, 05:43 pm CET
ISIN
US44930G1076
Symbol
ICUI

ICU Medical, Inc. Stock price

$136.97
-0.83 0.60% 1M
-33.85 19.82% 6M
-18.20 11.73% YTD
+38.68 39.35% 1Y
-75.34 35.49% 3Y
-80.85 37.12% 5Y
+52.00 61.20% 10Y
Nasdaq, Closing price Thu, May 01 2025
+0.38 0.28%
ISIN
US44930G1076
Symbol
ICUI
Sector

Key metrics

Market capitalization $3.37b
Enterprise Value $4.71b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 37.74
EV/Sales (TTM) EV/Sales 1.98
P/S ratio (TTM) P/S ratio 1.42
P/B ratio (TTM) P/B ratio 1.71
Revenue growth (TTM) Revenue growth 5.28%
Revenue (TTM) Revenue $2.38b
EBIT (operating result TTM) EBIT $91.34m
Free Cash Flow (TTM) Free Cash Flow $124.66m
Cash position $308.57m
EPS (TTM) EPS $-4.83
P/E forward negative
P/S forward 1.43
EV/Sales forward 2.00
Short interest 5.13%
Show more

Is ICU Medical, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,792 stocks worldwide.

ICU Medical, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a ICU Medical, Inc. forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a ICU Medical, Inc. forecast:

Buy
83%
Hold
17%

Financial data from ICU Medical, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,379 2,379
5% 5%
100%
- Direct Costs 1,560 1,560
1% 1%
66%
819 819
15% 15%
34%
- Selling and Administrative Expenses 419 419
211% 211%
18%
- Research and Development Expense 89 89
4% 4%
4%
311 311
36% 36%
13%
- Depreciation and Amortization 220 220
52% 52%
9%
EBIT (Operating Income) EBIT 91 91
221% 221%
4%
Net Profit -118 -118
297% 297%
-5%

In millions USD.

Don't miss a Thing! We will send you all news about ICU Medical, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

ICU Medical, Inc. Stock News

Neutral
PRNewsWire
one day ago
The partnership creates one of the largest global IV solutions manufacturing networks with combined production of an estimated 1.4 billion annual units and aims to bring additional supply chain resiliency and new innovation to the North American IV solutions market. SAN CLEMENTE, Calif.
Neutral
GlobeNewsWire
8 days ago
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating ICU Medical, Inc. (Nasdaq: ICUI) for potential securities law violations. Investors who have lost money in their ICU Medical, Inc. investment should contact the firm to learn more about how they might recover those losses.
Neutral
GlobeNewsWire
8 days ago
SAN CLEMENTE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2025 earnings release and conference call.
More ICU Medical, Inc. News

Company Profile

ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Head office United States
CEO Vivek Jain
Employees 15,000
Founded 1984
Website www.icumed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today